ASTRAZEN.NS ASTRAZEN NSE
₹8,631.50
+9.38% 1Y
Market & Price
Market Cap
-
Current Price
₹8,631.50
High / Low (52W)
₹10,473.70 / ₹7,765.50
Beta
-
Valuation
Stock P/E
-
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
₹-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
-
Profitability & Returns
ROCE
25.48%
ROE
-
ROA
-
Profit Margin
-
Op Margin
-
EPS (Latest Qtr)
₹17.95
EPS (TTM)
₹-
Balance Sheet & Liquidity
Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
₹1,989.10 Cr
Current Assets
₹1,739.93 Cr
Working Capital
₹758.12 Cr
Ownership
Promoter Holding
-
Chg in Prom Hold
-
FII / Inst Holding
-
Chg in FII Hold
-
Financial Snapshot
Enterprise Value
-
Total Revenue (TTM)
-
EBITDA
-
Free Cash Flow
-
Operating Cash Flow
-
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Growth (CAGR)
Revenue 5Y
31.40%
Profit 5Y
23.61%
Revenue (YoY)
-
Earnings (YoY)
-
PROS
- Healthy ROCE of 25.5%.
- Compounding revenue at 31.4% over 5 years.
- Profit CAGR of 23.6% over 5 years.
CONS
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Ad space
Quarterly Results
Figures in INR.
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | - | - | 480.48 Cr | 526.31 Cr | 559.09 Cr | 611.57 Cr | 578.61 Cr |
| Cost of Revenue | - | - | 259.61 Cr | 295.41 Cr | 324.49 Cr | 366.39 Cr | 394.25 Cr |
| Gross Profit | - | - | 220.87 Cr | 230.90 Cr | 234.60 Cr | 245.18 Cr | 184.36 Cr |
| Operating Expenses | - | - | 152.19 Cr | 166.36 Cr | 161.99 Cr | 204.19 Cr | 129.05 Cr |
| Operating Income | - | - | 68.68 Cr | 64.54 Cr | 72.61 Cr | 40.99 Cr | 55.31 Cr |
| EBITDA | - | - | 96.84 Cr | 91.99 Cr | 76.06 Cr | 51.44 Cr | 65.78 Cr |
| Interest Expense | - | - | 68.00 L | 72.00 L | 67.00 L | 1.06 Cr | 2.04 Cr |
| Pretax Income | - | - | 78.47 Cr | 74.70 Cr | 72.82 Cr | 46.54 Cr | 58.14 Cr |
| Tax Provision | - | - | 20.22 Cr | 18.87 Cr | 18.60 Cr | 13.95 Cr | 13.26 Cr |
| Net Income | - | - | 58.25 Cr | 55.83 Cr | 54.22 Cr | 32.59 Cr | 44.88 Cr |
| Diluted EPS | 15.37 | - | 23.30 | 22.33 | 21.69 | 13.04 | 17.95 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 1,002.97 Cr | 1,295.53 Cr | 1,716.29 Cr | 2,275.58 Cr |
| Cost of Revenue | - | 425.26 Cr | 673.26 Cr | 963.01 Cr | 1,380.54 Cr |
| Gross Profit | - | 577.71 Cr | 622.27 Cr | 753.28 Cr | 895.04 Cr |
| Operating Expenses | - | 428.82 Cr | 450.84 Cr | 539.30 Cr | 661.59 Cr |
| Operating Income | - | 148.89 Cr | 171.43 Cr | 213.98 Cr | 233.45 Cr |
| EBITDA | - | 150.99 Cr | 235.68 Cr | 197.81 Cr | 285.27 Cr |
| Interest Expense | - | 63.00 L | 1.20 Cr | 1.46 Cr | 4.49 Cr |
| Pretax Income | - | 134.10 Cr | 219.54 Cr | 156.36 Cr | 252.20 Cr |
| Tax Provision | - | 34.81 Cr | 58.03 Cr | 40.62 Cr | 64.68 Cr |
| Net Income | - | 99.29 Cr | 161.51 Cr | 115.74 Cr | 187.52 Cr |
| Diluted EPS | - | 39.70 | 64.60 | 46.30 | 75.01 |
Compounded Sales Growth
| 5 Years: | 31.40% |
| 1 Year: | - |
Compounded Profit Growth
| 5 Years: | 23.61% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | +9.38% |
| 6 Months: | -3.97% |
| 3 Months: | -2.67% |
| 1 Month: | +3.14% |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 984.87 Cr | 1,078.03 Cr | 1,518.12 Cr | 1,989.10 Cr |
| Current Assets | - | 835.47 Cr | 932.71 Cr | 1,342.35 Cr | 1,739.93 Cr |
| Cash & Equivalents | - | 500.34 Cr | 505.57 Cr | 536.14 Cr | 447.72 Cr |
| Inventory | - | 190.21 Cr | 227.88 Cr | 548.50 Cr | 1,027.33 Cr |
| Receivables | - | 107.52 Cr | 153.13 Cr | 184.88 Cr | 213.68 Cr |
| Total Liabilities | - | 396.18 Cr | 366.11 Cr | 747.77 Cr | 1,116.31 Cr |
| Current Liabilities | - | 383.93 Cr | 357.12 Cr | 703.00 Cr | 981.81 Cr |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 7.21 Cr | 4.59 Cr | 35.73 Cr | 110.66 Cr |
| Total Equity | - | 588.69 Cr | 711.92 Cr | 770.35 Cr | 872.79 Cr |
| Shares Outstanding | - | 2.50 Cr | 2.50 Cr | 2.50 Cr | 2.50 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 58.29 Cr | 27.87 Cr | 65.36 Cr | -15.14 Cr |
| Investing Cash Flow | - | 18.11 Cr | 21.74 Cr | 30.80 Cr | 18.69 Cr |
| Financing Cash Flow | - | -24.48 Cr | -44.38 Cr | -65.59 Cr | -91.97 Cr |
| Capital Expenditure | - | -8.52 Cr | -10.76 Cr | -1.75 Cr | -3.61 Cr |
| Free Cash Flow | - | 49.77 Cr | 17.11 Cr | 63.61 Cr | -18.75 Cr |
| Net Change in Cash | - | 51.92 Cr | 5.23 Cr | 30.57 Cr | -88.42 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 57.6% | 48.0% | 43.9% | 39.3% |
| Operating Margin % | - | 14.8% | 13.2% | 12.5% | 10.3% |
| Net Margin % | - | 9.9% | 12.5% | 6.7% | 8.2% |
| ROE % | - | 16.9% | 22.7% | 15.0% | 21.5% |
| ROCE % | - | 24.8% | 23.8% | 26.3% | 23.2% |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ASTRAZEN
No recent headlines available.